Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Sep 14;96(19):10637-42.
doi: 10.1073/pnas.96.19.10637.

Detoxification of environmental mutagens and carcinogens: structure, mechanism, and evolution of liver epoxide hydrolase

Affiliations

Detoxification of environmental mutagens and carcinogens: structure, mechanism, and evolution of liver epoxide hydrolase

M A Argiriadi et al. Proc Natl Acad Sci U S A. .

Abstract

The crystal structure of recombinant murine liver cytosolic epoxide hydrolase (EC 3.3.2.3) has been determined at 2.8-A resolution. The binding of a nanomolar affinity inhibitor confirms the active site location in the C-terminal domain; this domain is similar to that of haloalkane dehalogenase and shares the alpha/beta hydrolase fold. A structure-based mechanism is proposed that illuminates the unique chemical strategy for the activation of endogenous and man-made epoxide substrates for hydrolysis and detoxification. Surprisingly, a vestigial active site is found in the N-terminal domain similar to that of another enzyme of halocarbon metabolism, haloacid dehalogenase. Although the vestigial active site does not participate in epoxide hydrolysis, the vestigial domain plays a critical structural role by stabilizing the dimer in a distinctive domain-swapped architecture. Given the genetic and structural relationships among these enzymes of xenobiotic metabolism, a structure-based evolutionary sequence is postulated.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Ribbon plot of the epoxide hydrolase dimer, color-coded as follows: C-terminal catalytic domain, blue; N-terminal vestigial domain, green; and linker, red. Dotted green lines indicate the disordered Ala-20–Glu-47 and Val-64–Ser-89 segments in monomer A. The location of the active site is indicated by the bound inhibitor CPU. This figure was prepared with bobscript and Raster3D (–49).
Figure 2
Figure 2
Omit electron density map (contoured at 3.1σ) of the complex between sEH and the competitive inhibitor CPU (Ki = 3.1 nM). Note that the urea moiety of CPU binds with cis-(3-phenyl)propyl and trans-cyclohexyl amide linkages.
Figure 3
Figure 3
Proposed mechanism of sEH in the hydrolysis of trans-β-methylstyrene oxide. Nucleophilic attack of Asp-333 yields the alkylenzyme ester intermediate, which is subsequently hydrolyzed (with the assistance of general base His-523) to yield the vicinal diol product.
Figure 4
Figure 4
(Left) Least-squares superposition of the vestigial active site of sEH with the active site of haloacid dehalogenase. (Right) Least-squares superposition of the active site of sEH with that of haloalkane dehalogenase.
Figure 5
Figure 5
Proposed structure-based evolutionary pathway of xenobiotic catabolism. Haloalkane dehalogenase (blue) and haloacid dehalogenase (green) ancestors underwent an early gene fusion event to yield a primitive monomeric protein adopting a postulated closed conformation. Subsequent equilibration with an open conformation and dimerization through domain-swapping is facilitated by a flexible linker (i.e., hinge loop; red); stabilization of the modern-day, domain-swapped sEH dimer is achieved through subsequent shortening and/or amino acid substitutions that rigidify the 16-residue linker, which in sEH contains 5 proline residues. This figure was prepared with bobscript and Raster3D (–49).

References

    1. Wixtrom R N, Hammock B D. In: Biochemical Pharmacology and Toxicology. Zakim D, Vessey D A, editors. Vol. 1. New York: Wiley; 1985. pp. 1–93.
    1. Oesch F. Xenobiotica. 1973;3:305–340. - PubMed
    1. Ota K, Hammock B D. Science. 1980;207:1479–1481. - PubMed
    1. Arand M, Grant D F, Beetham J K, Friedberg T, Oesch F, Hammock B D. FEBS Lett. 1994;338:251–256. - PubMed
    1. Beetham J K, Grant D, Arand M, Garbarino J, Kiyosue T, Pinot F, Oesch F, Belknap W R, Shinozaki K, Hammock B D. DNA Cell Biol. 1995;14:61–71. - PubMed

Publication types

MeSH terms